Burning Rock Biotech Limited
BNR
$9.02
$0.010.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.81% | 47.91% | 40.92% | 28.69% | 37.19% |
| Total Depreciation and Amortization | -60.76% | -60.76% | 7.14% | 7.14% | 7.14% |
| Total Amortization of Deferred Charges | -58.12% | -58.12% | -42.75% | -42.75% | -42.75% |
| Total Other Non-Cash Items | -54.95% | -25.64% | -25.17% | 27.61% | -13.95% |
| Change in Net Operating Assets | 29.70% | 29.70% | -359.99% | -359.99% | -359.99% |
| Cash from Operations | 59.28% | 64.98% | 59.72% | 65.00% | 58.86% |
| Capital Expenditure | 32.88% | 32.88% | 88.65% | 88.65% | 88.65% |
| Sale of Property, Plant, and Equipment | 1,775.86% | 1,775.86% | -96.59% | -96.59% | -96.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.37% | 64.27% | -92.54% | -91.25% | -99.59% |
| Cash from Investing | 53.95% | 53.83% | 72.57% | 85.35% | -363.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 98.97% | 98.97% | 90.29% | 90.29% | 90.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -70.53% | -167.56% | -414.24% |
| Cash from Financing | 99.85% | 99.85% | 96.66% | -237.46% | 45.37% |
| Foreign Exchange rate Adjustments | -57.42% | -8.03% | -526.36% | -113.28% | -75.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.67% | 70.69% | 64.13% | 54.29% | 53.39% |